股票 › NBIX
神经分泌生物科学 NBIX
美股市值排名 #1052
$164.63 +$4.87 (+3.05%)
休市 · Nov 6, 10:00 pm ET · 最新盘后价 $164.63 0.00%
开盘$159.98
昨收$159.76
当日区间$158.66 – $165.86
成交量1.51M
市值$16.66B
市盈率（TTM）24.4
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$959.00M+39.5% YoY
营业利润$153.00M+5.1% YoY
净利润$144.40M+34.3% YoY
摊薄每股收益$1.39+31.1% YoY
自由现金流$128.60M+43.7% YoY
经营现金流$136.40M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
毛利率97.9%
营业利润率23.9%
净利率20.9%
净资产收益率22.1%
资产收益率15.3%
投入资本回报率19.5%
流动比率1.87
负债/资产比率31.1%
现金及投资$389.80M
总负债$401.80M
净现金（净负债）-$12.00M
自由现金流/营收25.8%
营收构成
2026/Q2 季度
按业务线
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 报告营业总收入 | $959.00M | $814.50M | $2.86B | $805.50M | $794.90M |
| 营业总收入 | $959.00M | $814.50M | $2.86B | $805.50M | $794.90M |
| 营业成本 | $23.20M | $13.80M | $52.10M | $17.60M | $14.00M |
| 毛利润 | $935.80M | $800.70M | $2.81B | $787.90M | $780.90M |
| 营业费用 | $782.80M | $614.70M | $2.17B | $560.00M | $541.60M |
| 销售及管理费用 | $439.70M | $318.50M | $1.16B | $301.80M | $291.60M |
| 研发费用 | $326.70M | $296.20M | $1.02B | $258.20M | $250.00M |
| 折旧、摊销与折耗 | $16.40M | – | – | – | – |
| -折旧与摊销 | $16.40M | – | – | – | – |
| 营业利润 | $153.00M | $186.00M | $636.50M | $227.90M | $239.30M |
| 非经营性利息净收入（支出） | -$2.90M | – | $90.30M | – | – |
| 非经营性利息支出 | $2.90M | – | – | – | – |
| 其他收入（支出） | $12.10M | $60.80M | -$21.40M | -$78.80M | $52.50M |
| 证券出售收益 | $13.60M | $53.40M | -$4.00M | -$61.80M | $52.80M |
| 特殊收益（费用） | -$1.50M | $7.40M | -$17.40M | -$17.00M | -$300,000.00 |
| -减：其他特殊支出 | $1.50M | $21.20M | $17.40M | $17.00M | $300,000.00 |
| -业务出售收益 | $0.00 | $28.60M | – | – | – |
| 税前利润 | $162.20M | $246.80M | $705.40M | $239.40M | $291.80M |
| 税费 | $17.80M | $48.90M | $226.80M | $85.70M | $82.30M |
| 净利润 | $144.40M | $197.90M | $478.60M | $153.70M | $209.50M |
| 持续经营利润 | $144.40M | $197.90M | $478.60M | $153.70M | $209.50M |
| 归属母公司净利润 | $144.40M | $197.90M | $478.60M | $153.70M | $209.50M |
| 归属普通股股东净利润 | $144.40M | $197.90M | $478.60M | $153.70M | $209.50M |
| 基本每股收益 | $1.43 | $1.97 | $4.81 | $1.54 | $2.11 |
| 摊薄每股收益 | $1.39 | $1.91 | $4.67 | $1.48 | $2.04 |
| 非经营性利息收入 | – | – | $90.30M | – | – |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $5.36B | $4.91B | $4.63B | $4.63B | $4.27B |
| 流动资产合计 | $1.64B | $2.44B | $2.52B | $2.52B | $2.16B |
| 现金及现金等价物与短期投资 | $389.80M | $1.32B | $1.48B | $1.48B | $1.11B |
| -现金及现金等价物 | $332.40M | $266.50M | $713.00M | $713.00M | $340.20M |
| -短期投资 | $57.40M | $1.05B | $767.40M | $767.40M | $774.60M |
| 应收款 | $887.00M | $768.10M | $686.80M | $686.80M | $728.00M |
| -应收账款 | $887.00M | $768.10M | $686.80M | $686.80M | $728.00M |
| 预付资产 | $217.10M | $224.80M | $170.70M | $170.70M | $178.10M |
| 存货 | $104.20M | $64.50M | $69.00M | $69.00M | $69.30M |
| 其他流动资产 | $39.40M | $62.50M | $115.80M | $115.80M | $68.20M |
| 非流动资产合计 | $3.72B | $2.47B | $2.11B | $2.11B | $2.11B |
| 固定资产净值 | $538.50M | $538.00M | $545.20M | $545.20M | $566.20M |
| -固定资产原值 | $538.50M | $538.00M | $663.50M | $663.50M | $566.20M |
| 投资及预付款 | $239.20M | $1.48B | $1.18B | $1.18B | $1.12B |
| -可供出售证券 | $239.20M | $1.48B | $1.18B | $1.18B | $1.12B |
| 商誉及其他无形资产 | $2.73B | – | – | – | $35.70M |
| -商誉 | $500.60M | – | – | – | – |
| -其他无形资产 | $2.23B | – | – | – | $35.70M |
| 一年以上递延资产 | $8.90M | $381.40M | $320.30M | $320.30M | $368.50M |
| 其他非流动资产 | $208.40M | $73.60M | $59.50M | $59.50M | $20.30M |
| 负债合计 | $1.67B | $1.50B | $1.38B | $1.38B | $1.26B |
| 流动负债合计 | $874.50M | $831.70M | $743.40M | $743.40M | $638.00M |
| 应付款 | $256.60M | $306.40M | $172.90M | $172.90M | $119.90M |
| -应付账款 | $142.00M | $120.00M | $104.90M | $104.90M | $119.90M |
| -应付税款合计 | $114.60M | $186.40M | $68.00M | $68.00M | – |
| 一年内应计费用 | $136.40M | $153.60M | $146.60M | $146.60M | $121.40M |
| 一年内预提费用 | $292.10M | $231.30M | $226.00M | $226.00M | $237.90M |
| 其他流动负债 | $66.20M | $58.70M | $69.10M | $69.10M | $53.70M |
| 非流动负债合计 | $791.00M | $667.10M | $635.00M | $635.00M | $624.10M |
| 长期应付账款及其他应付款 | $262.20M | $241.30M | $214.50M | $214.50M | $195.50M |
| 长期债务及融资租赁负债 | $401.80M | $406.20M | $415.30M | $415.30M | $428.40M |
| -长期融资租赁负债 | $401.80M | $406.20M | $415.30M | $415.30M | $428.40M |
| 一年以上递延负债 | $91.50M | – | – | – | – |
| 其他非流动负债 | $35.50M | $19.60M | $5.20M | $5.20M | $200,000.00 |
| 股东权益合计 | $3.69B | $3.41B | $3.25B | $3.25B | $3.00B |
| 股东权益 | $3.69B | $3.41B | $3.25B | $3.25B | $3.00B |
| 股本 | $100,000.00 | $100,000.00 | $100,000.00 | $100,000.00 | $100,000.00 |
| -普通股 | $100,000.00 | $100,000.00 | $100,000.00 | $100,000.00 | $100,000.00 |
| -优先股 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 资本公积 | $2.96B | $2.82B | $2.79B | $2.79B | $2.70B |
| 留存收益 | $724.00M | $589.60M | $447.70M | $447.70M | $294.00M |
| 不影响留存收益的损益 | $5.10M | $400,000.00 | $13.10M | $13.10M | $13.20M |
| -累计折旧 | – | – | -$118.30M | -$118.30M | – |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | $136.40M | $145.80M | $782.70M | $388.40M | $227.50M |
| 持续经营经营活动现金流净额 | $136.40M | $145.80M | $782.70M | $388.40M | $227.50M |
| 持续经营净利润 | $144.40M | $197.90M | $478.60M | $153.70M | $209.50M |
| 持续经营损益 | $5.20M | -$28.60M | – | – | – |
| 折旧、折耗与摊销 | $24.80M | $7.30M | $30.10M | $7.50M | $7.70M |
| 递延税款 | -$25.30M | -$61.10M | $165.40M | $48.20M | $168.30M |
| 其他非现金项目 | $3.60M | $1.40M | $14.80M | $3.90M | $3.40M |
| 营运资金变动 | -$80.10M | -$3.00M | -$128.80M | $119.20M | -$185.20M |
| -应收款变动 | -$84.30M | -$81.40M | -$210.50M | $38.40M | -$132.30M |
| -存货变动 | -$6.50M | $4.30M | -$15.30M | -$3.40M | -$12.30M |
| -应付账款及应计费用变动 | -$8.50M | -$14.30M | $160.20M | $76.50M | $71.60M |
| -其他营运资金变动 | $19.20M | $88.40M | -$63.20M | $7.70M | -$112.20M |
| 投资活动现金流净额 | -$135.40M | -$506.20M | -$264.40M | -$52.90M | -$196.70M |
| 持续经营投资活动现金流净额 | -$135.40M | -$506.20M | -$264.40M | -$52.90M | -$196.70M |
| 资本支出 | -$7.80M | -$9.10M | -$34.00M | $2.40M | -$13.20M |
| 业务购买及出售净额 | -$2.36B | $63.20M | – | – | – |
| 投资购置及出售净额 | $2.23B | -$560.30M | -$230.40M | -$55.30M | -$183.50M |
| 筹资活动现金流 | $63.40M | -$86.10M | -$38.30M | $37.30M | $45.60M |
| 持续经营筹资活动现金流净额 | $63.40M | -$86.10M | -$38.30M | $37.30M | $45.60M |
| 普通股发行净额 | -$12.00M | -$54.00M | -$167.70M | $0.00 | $0.00 |
| 股票期权行使所得 | $84.80M | $23.60M | $129.40M | $37.30M | $45.60M |
| 其他筹资费用净额 | -$9.40M | -$55.70M | – | – | – |
| 期末现金余额 | $338.90M | $274.50M | $721.00M | $721.00M | $348.20M |
| 现金净变动 | $64.40M | -$446.50M | $480.00M | $372.80M | $76.40M |
| 期初现金余额 | $274.50M | $721.00M | $241.00M | $348.20M | $272.00M |
| 自由现金流 | $128.60M | $136.70M | $748.70M | $390.80M | $214.30M |
| 债务发行及偿还净额 | – | – | $0.00 | $0.00 | $0.00 |
| 汇率变动影响 | – | – | $0.00 | $0.00 | -$200,000.00 |
暂无评论——快来第一个聊聊 NBIX。